- Investing Ideas
- U.K. Biotech Stocks
U.K. Biotech Stocks
Results
24
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
24 companies
AstraZeneca
Market Cap: UK£214.1b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£134.34
7D
-3.5%
1Y
27.0%
GSK
Market Cap: UK£75.1b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£18.43
7D
-3.8%
1Y
21.5%
Haleon
Market Cap: UK£29.8b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.27
7D
-4.9%
1Y
-21.1%
Hikma Pharmaceuticals
Market Cap: UK£3.1b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£14.22
7D
-2.5%
1Y
-33.8%
Genus
Market Cap: UK£1.6b
Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£22.44
7D
-9.4%
1Y
12.2%
HUTCHMED (China)
Market Cap: UK£1.5b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCM
UK£1.80
7D
1.3%
1Y
-10.4%
Oxford Nanopore Technologies
Market Cap: UK£1.4b
Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
ONT
UK£1.36
7D
5.1%
1Y
11.9%
Oxford Biomedica
Market Cap: UK£759.4m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£6.16
7D
-0.3%
1Y
87.5%
PureTech Health
Market Cap: UK£337.9m
Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
PRTC
UK£1.33
7D
-3.2%
1Y
-3.5%
Diaceutics
Market Cap: UK£121.1m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.44
7D
-13.5%
1Y
4.7%
Bioventix
Market Cap: UK£87.5m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£16.60
7D
-0.9%
1Y
-42.8%
hVIVO
Market Cap: UK£57.0m
Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.
HVO
UK£0.083
7D
1.9%
1Y
-22.9%
SkinBioTherapeutics
Market Cap: UK£25.1m
A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.
SBTX
UK£0.097
7D
0%
1Y
-48.3%
Palatin Technologies
Market Cap: US$25.9m
A biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.
0KF3
US$14.80
7D
2.3%
1Y
211.3%
IXICO
Market Cap: UK£18.9m
Provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally.
IXI
UK£0.086
7D
0%
1Y
-21.4%
Solvonis Therapeutics
Market Cap: UK£17.0m
A clinical-stage biopharmaceutical company, develops medicines for addiction, psychiatry, and neurology disorders.
SVNS
UK£0.0025
7D
2.0%
1Y
88.7%
ProBiotix Health
Market Cap: UK£11.5m
Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.
PBX
UK£0.072
7D
-7.9%
1Y
-12.1%
Cardiogeni
Market Cap: UK£6.7m
A clinical stage biotechnology company, develops heart failure medicines.
CGNI
UK£0.07
7D
0%
1Y
16.7%
Verici Dx
Market Cap: UK£6.4m
Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.
VRCI
UK£0.0043
7D
0%
1Y
-69.1%
Theracryf
Market Cap: UK£5.2m
A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.
TCF
UK£0.0024
7D
4.3%
1Y
-12.7%
Proteome Sciences
Market Cap: UK£4.9m
Provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.
PRM
UK£0.014
7D
-6.0%
1Y
-57.8%
Futura Medical
Market Cap: UK£3.8m
Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.
FUM
UK£0.007
7D
4.8%
1Y
-92.4%
Physiomics
Market Cap: UK£3.2m
Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.
PYC
UK£0.007
7D
7.7%
1Y
68.7%
BSF Enterprise
Market Cap: UK£2.9m
Develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong.
BSFA
UK£0.022
7D
45.2%
1Y
-5.3%